Please login to the form below

Not currently logged in
Email:
Password:

Exondys

This page shows the latest Exondys news and features for those working in and with pharma, biotech and healthcare.

FDA will maintain the pace, vows Woodcock, but warns of skills gap

FDA will maintain the pace, vows Woodcock, but warns of skills gap

These cases have, of course, not been without controversy – one of the most notable being the approval of Sarepta’s Duchenne treatment Exondys 51 in 2016, despite questionable data.

Latest news

More from news
Approximately 4 fully matching, plus 11 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics